A series of new 4-(substitutedphenyl)-N,N-bis(4-(trifluoromethyl)benzyl)thiazol-2-amines (6a-j) and 4-(4- chlorophenyl)-N,N-bis(4-methoxybenzyl)thiazol-2-amines (7a-j) have been synthesized. All the newly synthesized compounds are characterized by IR, 1H NMR, 13C NMR and mass spectral studies. Compound 6h has shown promising α-glucosidase inhibitory activity, while compound 6j and 7f have displayed significant anticancer potential against neuroblastoma cells. Some of the targets have shown promising α-glucosidase inhibitory and anticancer activity.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report